Skip to main content

Table 1 Clinicopathological characteristics of patients with thymoma. Tumor stages are defined by Masaoka-Koga classification

From: Using proteomic profiling to characterize protein signatures of different thymoma subtypes

Factors Number (%)
Age
60 6 (28.6)
  < 60 15 (71.4)
Gender
 Male 10 (47.6)
 Female 11 (52.4)
Stage
 I 9 (42.9)
 II 7 (33.3)
 III 2 (9.5)
 IV 3 (14.3)
WHO classification
 AB 8 (38.1)
 B2 8 (38.1)
 B3 5 (23.8)